RAMB Julho/Agosto 2015

103 / 105

A review on alcohol: from the central action mechanism to chemical dependency
Rev Assoc Med B ras 2015; 61(4):381-387 387
14. Zheng G, ZhangW, Zhang Y, Chen Y, LiuM, Yao T, et. al. Gamma-aminobutyric
acid(A) (GABA(A)) receptor regulates ERK1/2 phosphorylation in rat
hippocampus in high doses of methyl tert-butyl ether (MTBE)-induced
impairment of spatial memory. Toxicol Appl Pharmacol. 2009; 236(2):239-45.
15. Lombroso P. Aprendizado e memória. Rev Bras Psiquiatr. 2004; 26(3):207-10.
16. Young C, Straiko MM, Johnson SA, Creeley C, Olney JW. Ethanol causes
and lithium prevents neuroapoptosis and suppression of perk in the infant
mouse brain. Neurobiol Dis. 2008; 31(3):355-60.
17. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease.
Seminars Liver Dis. 1998; 8(1):12-25.
18. Gruol DL, Parsons KL, DiJulio N. Acute ethanol alters calcium signals
elicited by glutamate receptor agonists and K depolarization in cultured
cerebellar Purkinje neurons. Brain Res. 1997; 773(1):82-9.
19. Castro LA, Baltieri DA. Tratamento farmacológico da dependência do álcool.
Rev Bras Psiq. 2004; 26(supl.):43-6.
20. Mayer M, Westbrook G. Permeation and block of NMDA receptor channels
by divalent cations in mouse cultured central neurons. J Physiol. 1987;
394(1):501-27.
21. Hartley DM, Kurth MC, Bjerkness L, Weiss JH, Choi DW. Glutamate receptor-
induced 45Ca2+ accumulation in cortical cell culture correlates with
subsequent neuronal degeneration. J Neurosci. 1993; 13(5):1993-2000.
22. Tymian M, Charlton MP, Carlen PL, Tator, CH. Source specificity of early
calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci.
1993; 13(5):2085-104.
23. Clapp P, Bhave SJ, Hoffman PL. How adaptation of the brain to alcohol
leads to dependence: a pharmacological perspective. Alcohol Res Health.
2008; 31(4):310-39.
24. Chang-Mu C, Jen-Kun L, Shing-Hwa L, Shoei-Yn LS. Characterization of
neurotoxic effects of NMDA and the novel neuroprotection by
phytopolyphenols in mice. Behav Neurosci. 2010; 124(4):541-53.
25. Bittencourt AL. Mecanismo de ação do etanol: envolvimento de etanol, gaba
e dopamina. Rev Psiq Clin. 2000; 27(1):26-31.
26. Aminoff MJ. Neurology and General Medicine. 4.ed. Churchill Living, 2007.
27. Gilpin NW, Koob GF. Neurobiology of alcohol dependence: focus on
motivational mechanisms. Alcohol Res. Health. 2008; 31(3):185-95.
28. World Health Organization. Neuroscience of Psychoactive Substance Use
and Dependence. 1.ed. Geneva: WHO Library Catouloguing-in-Publication
Data, 2004. Chapter 1-2. p.1-40.
29. Zaleski M, Morato GS, Silva VA, Lemos T. Aspectos neurofarmacológicos
do uso crônico e da síndrome de abstinência do álcool. Rev Bras Psiquiatr.
2004; 26(1):40-2.
30. Martins HS, Neto As, Velasco IT. Emergências Clínicas Baseadas em
Evidências. Disciplina de Emergências Clínicas do Hospital das Clínicas da
Faculdade de Medicina de São Paulo. São Paulo: Atheneu, 2005.
31. Pradhan AA, Befort K, Nozaki K, Ruff CG, Kieffer BL. The delta opioid
receptor: an evolving target for the treatment of brain disorders. Trends
Pharmacol Sci. 2011; 32(10):581-90.
32. Lovinger DM. O papel da serotonina anos efeitos do álcool sobre o cérebro.
Alcohol Health Res World. 1997; 21(2):114-20.
33. Vengelien V, Bilbao A, Molander A, Spanagel R. Neuropharmacology of
alcohol addiction. Br. J Pharmacol. 2008; 154(2):299-15.
34. Boullosa O, Lopez-Mato AM. Recent advances in the serotonin
neurotransmitters configuration. Psiquiatr Biol. 1995; 3(3):37-51.
35. Laranjeira R, Nicastri S, Jerônimo C, Marques AC. Consenso sobre a síndrome
de abstinência do álcool (SAA) e o seu tratamento. Rev Bras Psiquiatr. 2000;
22(2):62-71.
36. Lee R, Petty, F, Coccaro, EF. Cerebrospinal fluid GABA concentration:
Relationship with impulsivity and history of suicidal behavior, but not
aggression, in human subjects. J. Psychiatry Res. 2008; 43(4):353-9.
37. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional
diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002; 71(4):533-54.
38. Sartania N, Strange PG. Role of conserved serine residues in the interaction
of agonists with D3 dopamine receptors. J Neurochem. 2002; 72(6):2621-4.
39. Tomkins DM, Joharchi N, Tampakeras M, Martin JR, Wichmann J, Higgins
GA. An investigation of the role of 5-HT2C receptors inmodifying ethanol self-
administration behaviour. Pharmacol Biochem Behav. 2002; 71(4):735-44.
40. BlednovIA,CravattBF,BoehmSL,WalkerD,HarrisRA.Roleofendocannabinoids
inalcoholconsumptionand in lackingfattyacidamide
hydrolase. Neuropsychopharmacol. 2007; 32(7):1570-82.
41. Hoplight BJ, Sandygren NA, Neumaier JF. Increased expression of 5-HT1B
receptors in rat nucleus accumbens via virally mediated gene transfer increases
voluntary alcohol consumption. Alcohol. 2006; 38(2):73-9.
42. Risinger FO, Doan AM, Vickery AC. Oral operant ethanol self-administration
in 5-HT1b knockout mice. Behav Brain Res. 1999; 102(1-2):211-5.
43. Hodge CW, Kelley SP, Bratt AM, Iller K, Schroeder JP, Besheer J. 5-HT(3A)
receptor subunit is required for 5-HT3 antagonist-induced reductions in
alcohol drinking. Neuropsychopharmacol. 2004; 29(10):1807-13.
44. Carboni A, Frau R, Di Chiara G. Differential inhibitory effects of a 5-HT3
antagonist on drug-induced stimulation of dopamine release. Eur J
Pharmacol. 1989; 164(3):515-9.
45. Lovinger DM. Ethanol potentiation of 5HT3 receptor-mediated ion current
in NCB-20 neuroblastoma cells. Neurosci Lett. 1991; 122(1):57-60.
46. Ait-Daoud N, Johnoson BA, Prihioda TJ, Hargita ID. Combining ondansetron
and naltrexone reduces craving among biologically predisposed alcoholics:
preliminary clinical evidence. Psychopharmacol (Berl). 2001; 154(1):23-7.
47. Johnson BA, Roache JD, Javors MA, Diclemente CC, Cloninger CR, Prihoda
TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of
drinking among biologically predisposed alcoholic patients: a randomized
controlled trial. JAMA. 2000; 284(8):963-71.
48. Kranzler HR, Pierucci-Lagha A, Feinn R, Hernandez-Avila C . Effects of
ondansetron in early-versus late-onset alcoholics: a prospective, open-label
study. Alcohol Clin Exp Res. 2003; 27(7):1150-5.
49. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn
MJ. Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry. 1994;
51(9):720-31.
50. Cocaína e crack. In: Diehl A, Cordeiro DC, Laranjeira R, Lacerda ALT, Junior
AR, Bonadio AN, et al. (eds.). Dependência química. 1.ed. Porto Alegre:
Artmed, 2011. p.170-9.
51. Maconha.In:DiehlA,CordeiroDC,LaranjeiraR,LacerdaALT,JuniorAR,Bonadio
AN, et al. (eds.). Dependência química. 1.ed. Porto Alegre: Artmed, 2011. p.161-9.
52. Tabakoff B, Hoffman PL. Neurochemical correlates of ethanol withdrawal:
alterations in serotonergic function. J Pharm Pharmacol. 1977; 29(8):471-6.
53. Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, et
al. CannabinoidCB2 receptors protect against alcoholic liver desease by regulating
kupffer cell polarization in mice. Hepatology. 2011; 54(4):1217-26.
54. Hungund BL, Goldstein DB, Villegas F, Cooper TB. Formation of fatty acid
ethyl esters during chronic ethanol treatment in mice. Biochem Pharmacol.
1988; 37(15):3001-4.
55. Laposata EA, Lange LG. Presence of nonoxidative ethanol metabolism in
human organs commonly damaged by ethanol abuse. Science. 1986;
231(4737):497-9.
56. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Chronic ethanol
inhibits the anandamide transport and increases extracellular anandamide
levels in cerebellar granule neurons. Eur J Pharmacol. 2003; 466(1-2):73-83.
57. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Stimulation of
cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and
its modulation by specific neuromodulators in cerebellar granule neurons.
Biochem Biophys Acta. 2000; 1535(1):78-86.
58. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Chronic ethanol
administration down-regulates cannabinoid receptors in mouse brain
synaptic plasma membrane. Brain Res. 1998; 793(1-2):212-8.
59. Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J. Chronic ethanol
consumption regulates cannabinoid CB1 receptor gene expression in selected
regions of rat brain. Alcohol. 2004; 39(2):88-92.
60. Basavarajappa BS, Hungund, BL. Down-regulation of cannabinoid receptor
agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane
from chronic ethanol exposed mouse. Brain Res. 1999; 815(1):89-97.
61. Prafulla A, Hay D, Senyon C, Paul A, Slesinger AS. A discrete alcohol pocket
involved in GIRK channel activation. Nat Neurosci. 2009; 12(1):988-95.
62. Barbosa ADE, Morato GS. Influência da epipregnanolona sobre a modulação
da tolerância rápida ao etanol pelos neuroesteróides. Rev Bras Psiquiatr.
2007; 29(4):337-45.